NO20023875L - Stabilt nasalt, oralt eller sublingualt anvendbart preparat - Google Patents

Stabilt nasalt, oralt eller sublingualt anvendbart preparat

Info

Publication number
NO20023875L
NO20023875L NO20023875A NO20023875A NO20023875L NO 20023875 L NO20023875 L NO 20023875L NO 20023875 A NO20023875 A NO 20023875A NO 20023875 A NO20023875 A NO 20023875A NO 20023875 L NO20023875 L NO 20023875L
Authority
NO
Norway
Prior art keywords
sublingually
oral
stable
preparation
usable preparation
Prior art date
Application number
NO20023875A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023875D0 (no
Inventor
Helmut Scheidl
Gerhard Hantich
Ernst Hesse
Thomas Zapf
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3669975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023875(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Publication of NO20023875D0 publication Critical patent/NO20023875D0/no
Publication of NO20023875L publication Critical patent/NO20023875L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20023875A 2000-02-16 2002-08-15 Stabilt nasalt, oralt eller sublingualt anvendbart preparat NO20023875L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0023300A AT409081B (de) 2000-02-16 2000-02-16 Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
PCT/AT2001/000007 WO2001060394A1 (de) 2000-02-16 2001-01-10 Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
NO20023875D0 NO20023875D0 (no) 2002-08-15
NO20023875L true NO20023875L (no) 2002-10-11

Family

ID=3669975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023875A NO20023875L (no) 2000-02-16 2002-08-15 Stabilt nasalt, oralt eller sublingualt anvendbart preparat

Country Status (20)

Country Link
US (1) US20030119728A1 (cs)
EP (1) EP1255557B1 (cs)
JP (1) JP2003529562A (cs)
AT (2) AT409081B (cs)
AU (1) AU771251B2 (cs)
CA (1) CA2399822A1 (cs)
CZ (1) CZ20022686A3 (cs)
DE (1) DE50100958D1 (cs)
DK (1) DK1255557T3 (cs)
ES (1) ES2210121T3 (cs)
HU (1) HU229961B1 (cs)
NO (1) NO20023875L (cs)
NZ (1) NZ520396A (cs)
PL (1) PL357132A1 (cs)
PT (1) PT1255557E (cs)
SI (1) SI21026B (cs)
SK (1) SK285374B6 (cs)
TR (1) TR200400234T4 (cs)
WO (1) WO2001060394A1 (cs)
ZA (1) ZA200205868B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
AT413078B (de) * 2002-10-10 2005-11-15 Gebro Pharma Gmbh Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ES2243840T3 (es) 2003-07-25 2005-12-01 Ferring B.V. Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma.
EP1530967B1 (en) * 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
JP5079257B2 (ja) * 2005-05-16 2012-11-21 株式会社三和化学研究所 Ｂｕｒｋｈｏｌｄｅｒｉａｃｅｐａｃｉａに対する保存剤
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
BRPI0814986A2 (pt) 2007-08-06 2015-02-03 Serenity Pharmaceuticals Corp Métodos e dispositivos para a distribuição de fármaco desmopresina.
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PT2296686E (pt) 2008-05-21 2014-05-23 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono não perturbado por noctúria
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
SG11201510647TA (en) 2013-06-28 2016-01-28 Amgen Inc Stable liquid formulation of amg 416 (velcalcetide)
JP6341777B2 (ja) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス，エルエルシー 低用量デスモプレシンを含有する医薬組成物
CN106999538A (zh) * 2014-11-20 2017-08-01 阿勒根公司 包含去氨加压素与α‑肾上腺素能受体拮抗剂组合的方法和组合物
GB201721846D0 (en) * 2017-12-22 2018-02-07 Arecor Ltd Novel composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126014A (ja) * 1984-11-22 1986-06-13 Teijin Ltd 経鼻投与用水性液剤
JP2505430B2 (ja) * 1986-11-04 1996-06-12 帝人株式会社 塩基性アミノ酸を含有する経鼻投与用粉末状組成物
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
JPH0640948A (ja) * 1992-07-20 1994-02-15 Kyowa Hakko Kogyo Co Ltd イオントフォレシス用組成物
JP3628713B2 (ja) * 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
ATE318138T1 (de) * 1998-06-30 2006-03-15 Takeda Pharmaceutical Pharmazeutisches mittel zur behandlung von diabetes
CA2370520A1 (en) * 1999-04-16 2000-10-26 Komandoor Elayavalli Achyuthan Viral detection method using viral encoded enzymes and chemiluminescent substrates
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide

Also Published As

Publication number Publication date
PT1255557E (pt) 2004-04-30
TR200400234T4 (tr) 2004-03-22
DK1255557T3 (da) 2004-03-22
CZ20022686A3 (cs) 2003-01-15
EP1255557A1 (de) 2002-11-13
DE50100958D1 (de) 2003-12-18
AU771251B2 (en) 2004-03-18
ATE253928T1 (de) 2003-11-15
PL357132A1 (en) 2004-07-12
WO2001060394A1 (de) 2001-08-23
HU229961B1 (hu) 2015-03-30
SK10492002A3 (sk) 2003-02-04
US20030119728A1 (en) 2003-06-26
ZA200205868B (en) 2004-02-10
AU2652001A (en) 2001-08-27
NZ520396A (en) 2004-05-28
SI21026A (sl) 2003-04-30
SK285374B6 (sk) 2006-12-07
EP1255557B1 (de) 2003-11-12
HUP0204550A2 (en) 2003-05-28
CA2399822A1 (en) 2001-08-23
ES2210121T3 (es) 2004-07-01
SI21026B (sl) 2004-02-29
ATA2332000A (de) 2001-10-15
NO20023875D0 (no) 2002-08-15
JP2003529562A (ja) 2003-10-07
AT409081B (de) 2002-05-27
HUP0204550A3 (en) 2004-12-28

Similar Documents

Publication Publication Date Title
NO20023875L (no) Stabilt nasalt, oralt eller sublingualt anvendbart preparat
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
NO20010531L (no) Medisinske aerosolformuleringer
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
SI1898876T1 (sl) MUKOADHEZIVNE FARMACEVTSKE OBLIKE, KI VSEBUJEJO KSILOGlUKAN IN SO UPORABNE V MEDICINSKIH SREDSTVIH IN APLIKACIJSKIH OBLIKAH
ATE468845T2 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
NO20022201L (no) Lösninger inneholdende Epinastin
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
BRPI0014878B8 (pt) composição farmacêutica contendo ciclosonida para aplicação à mucosa
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
HRP20010764B1 (en) Prucalopride oral solution
ATE291421T1 (de) Pharmazeutische, ramipril enthaltende brauseformulierung
AR043536A1 (es) Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico
ES2159967T3 (es) Medicamento que contiene acido delta-aminolevulinico.
ATE408413T1 (de) Pralmorelin-haltige nasentropfen-präparate
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
BR0205625C1 (pt) Formulações nasais em gel
ES2189639B1 (es) Composicion acuosa que contiene acido acetilsalicilico.
MD1898G2 (ro) Remediu dermatologic stabilizat pe bază de juglonă
BG107987A (bg) Течна форма на комбинирано лекарствено средство за лечение на простудни и грипни заболявания
TH45760B (th) สารละลายพรูคาโลไพรด์สำหรับการให้ทางปาก

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application